Tok J, Szabolcs M J, Silvers D N, Zhong J, Matsushima A Y
Department of Dermatology, Columbia University-College of Physicians and Surgeons, New York, New York 10032, USA.
J Am Acad Dermatol. 1998 Mar;38(3):453-60. doi: 10.1016/s0190-9622(98)70505-5.
Early stages of cutaneous T-cell lymphoma (CTCL) may be difficult to distinguish from benign inflammatory dermatoses by routine histologic examination.
Our purpose was to determine whether clonal rearrangements of the T-cell receptor (TCR) gamma gene by polymerase chain reaction and denaturing gradient gel electrophoresis (PCR/DGGE) could be detected in the early stages of CTCL and to correlate these findings with conventional histopathology.
A total of 39 specimens from 12 patients with CTCL were obtained. The slides were evaluated independently by three dermatopathologists, and categorized into three groups: nondiagnostic, suggestive of CTCL, and diagnostic of CTCL. Of the 39 specimens, 33 were tested by PCR/DGGE by means of GC-clamped primers for clonal rearrangement of the TCR gamma gene.
The histologic evaluation of the 12 cases showed a significant variation among the three dermatopathologists. The correlation of PCR/DGGE with routine histology was as follows: Clonal TCR gamma gene rearrangements were demonstrated in 73% of the specimens nondiagnostic for CTCL, 71% of those suggestive of CTCL, and 74% of those diagnostic of CTCL.
Clonal TCR gamma gene rearrangements may be detected in patients with early CTCL, even when the histologic findings are not unequivocally diagnostic. In patients with multiple biopsy specimens, identical clones were demonstrated in all rearranged samples, indicating the same neoplastic clone was present in the earliest stages of disease.
皮肤T细胞淋巴瘤(CTCL)的早期阶段通过常规组织学检查可能难以与良性炎症性皮肤病相区分。
我们的目的是确定是否可以通过聚合酶链反应和变性梯度凝胶电泳(PCR/DGGE)检测到CTCL早期阶段的T细胞受体(TCR)γ基因的克隆重排,并将这些发现与传统组织病理学相关联。
共获取了12例CTCL患者的39份标本。三位皮肤病理学家独立评估玻片,并将其分为三组:非诊断性、提示CTCL、诊断为CTCL。在这39份标本中,33份通过PCR/DGGE使用GC夹引物检测TCRγ基因的克隆重排。
12例病例的组织学评估显示三位皮肤病理学家之间存在显著差异。PCR/DGGE与常规组织学的相关性如下:在非诊断为CTCL的标本中,73%检测到克隆性TCRγ基因重排;在提示CTCL的标本中,71%检测到;在诊断为CTCL的标本中,74%检测到。
即使组织学结果并非明确诊断,早期CTCL患者也可能检测到克隆性TCRγ基因重排。在有多个活检标本的患者中,所有重排样本中均显示出相同的克隆,表明在疾病的最早阶段存在相同的肿瘤克隆。